Press Releases

All Releases
AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference
Apr 20, 2017
ALBANY, N.Y. , April 20, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
Apr 06, 2017
ALBANY, N.Y. , April 06, 2017 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the pricing of the previously announced
AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders
Apr 06, 2017
ALBANY, N.Y. , April 06, 2017 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the
AngioDynamics Reports Fiscal 2017 Third Quarter Results
Mar 30, 2017
Q3 net sales of $85.6 million , down 2% year-over-year Q3 GAAP earnings per share of $0.08 ; non-GAAP adjusted EPS up 27% from Q3 fiscal 2016 Q3 operating cash generation of $14.4 million ; free cash flow generation of $14.0 million Revised FY2017 revenue and adjusted EPS guidance; free cash flow
AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City
Mar 27, 2017
ALBANY, N.Y. , March 27, 2017 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will host an Investor Day on April 6, 2017 in New York City , beginning at
AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results
Mar 20, 2017
ALBANY, N.Y. , March 20, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 third
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
Mar 14, 2017
ALBANY, N.Y. , March 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced it has received CE Mark certification for the Solero Microwave
AngioDynamics to Present at the Barclays Global Healthcare Conference
Mar 08, 2017
ALBANY, N.Y. , March 08, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
AngioDynamics Reports Fiscal 2017 Second Quarter Results
Jan 06, 2017
Q2 net sales of $89.0 million , down 0.3% year-over-year Q2 GAAP earnings per share of $0.37 ; non-GAAP adjusted EPS up 36% from Q2 Fiscal 2016 Q2 operating cash generation of $14.9 million ; free cash flow generation of $13.6 million Reiterated FY2017 revenue guidance; increased adjusted EPS and
AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017
ALBANY, N.Y. , Jan. 03, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer and
AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results
Dec 20, 2016
ALBANY, N.Y. , Dec. 20, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 second
AngioDynamics to Participate in Upcoming Investor Conferences
Nov 28, 2016
ALBANY, N.Y. , Nov. 28, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
Nov 14, 2016
ALBANY, N.Y. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the pricing of the previously announced
AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders
Nov 14, 2016
ALBANY, N.Y. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the
AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program
Nov 09, 2016
New Senior Credit Facility Includes a $100 Million TLA and a $150 Million RCF Board of Directors Authorizes Up to $25 Million in Share Repurchases ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for
AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc.
Nov 09, 2016
ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Eileen Auen and Jan Stern Reed to the
AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum
Nov 07, 2016
ALBANY, N.Y. , Nov. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
AngioDynamics Reports Fiscal 2017 First Quarter Results
Oct 05, 2016
Q1 net sales of $88.1 million , up 5% year-over-year Q1 GAAP earnings per share of $0.04 ; non-GAAP adjusted EPS of $0.17 Q1 operating cash generation of $7.4 million FY2017 guidance remains unchanged ALBANY, N.Y. , Oct. 05, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
Sep 21, 2016
ALBANY, N.Y. , Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
Sep 06, 2016
ALBANY, N.Y. , Sept. 06, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
Displaying 21 - 40 of 615

Copyright Nasdaq. Minimum 15 minutes delayed.